Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200057301Phase 4Not yet recruiting
Phase 4 trial of linaclotide in chronic constipation and bowel preparation, sponsored by The Affiliated People’s Hospital of Ningbo University. Primary endpoint: Bowel cleanliness. Planned start Mar 2022; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200057301.